DELAWARE - In response to recent federal changes, Delaware Insurance Commissioner Trinidad Navarro said Wednesday that most commercial health insurance carriers operating in the state have committed to maintaining coverage for immunizations, including COVID-19 vaccines.
Delaware Gov. Matt Meyer recently announced the state will join a regional public health coalition with other Northeast states to collaborate on vaccination guidelines, disease surveillance, emergency preparedness and support for state public health laboratories. The governor and the Division of Public Health also issued a standing order to ensure continued access to COVID-19 vaccines.
Brian Frazee, President and CEO of the Delaware Healthcare Association says, “the best way to prevent illness is to get vaccinated against flu, COVID-19, and if applicable, RSV.”
Several large carriers confirmed their positions:
Aetna CVS Health said it will continue to provide coverage for all approved vaccines, including COVID-19, without cost-sharing, as required by federal and state laws. It also noted that self-funded employer plans determine their own coverage.
- Delaware First Health (also known as Centene, Celtic, and Ambetter Health of Delaware) stated it remains committed to covering evidence-based treatments, including vaccines, and will continue aligning coverage with public health guidance.
- Highmark reported no changes to vaccine coverage or related medical policies and urged members to consult their physicians.
UnitedHealthcare said there have been no immediate changes to coverage for its commercial members and that it is monitoring evolving federal guidance.
“Vaccines save lives,” Delaware Insurance Commissioner Navarro said in a statement. “They save money, prevent costly diseases, keep insurance affordable, and preserve health care capacity, especially important as we face provider shortages.”
Navarro emphasized that the Department of Insurance will continue to monitor changes, collaborate with state partners and, if necessary, pursue regulatory or legislative actions to ensure vaccine access is not diminished.